TransEnterix (NYSE:TRXC) has filed a 510(k) submission to add an artificial intelligence feature to its robot-assisted surgery system in which the system can automatically move the camera for a surgeon. Surgeons have been able to move the camera on TransEnterix’s Senhance System via eye sensing. But the new Intelligent Surgical Unit would allow a surgeon, for […]
TransEnterix
TransEnterix seeks better 2020 after a tough 2019
TransEnterix (NYSE:TRXC) today reported preliminary 2019 revenue numbers that failed to meet the expectations of Wall Street analysts — but the robotic surgery company closed the year with two new customer agreements. Research Triangle Park, N.C.– based TransEnterix touts its Senhance System as a more economical option when it comes to laparoscopic and robotic systems, with […]
TransEnterix names interim chief financial officer
TransEnterix (NYSE:TRXC) this week said it appointed Brett Farabaugh as interim chief financial officer, effective Jan. 2. Farabaugh replaces Joe Slattery who retired on DEc. 31, 2019. “We are very excited to have Brett join the TransEnterix team. He brings a wealth of experience providing financial leadership to high growth healthcare and technology companies,” president and […]
TransEnterix announces reverse split of common stock
TransEnterix (NYSE:TRXC) announced that it will effect a 13-to-1 reverse split of the company’s common stock. The Morrisville, N.C.-based company said stockholders approved the reverse stock split range at a special meeting yesterday and authorized a share reduction by stockholders. The applicable certificate of amendment was filed in Delaware, becoming effective at 5 p.m. yesterday, according […]
TransEnterix slashes workforce amid disappointing Q3 results
TransEnterix (NYSE:TRXC) has let go of 39 employees, 18% of its headcount, as the robot-assisted surgery company turns its focus on existing Sehance system customers versus drumming up sales. “Our key areas of focus in 2020 will be on market develop activities, expanding the clinical economic evidence, supporting Senhance and adding important new features, such as […]
TransEnterix appoints new president and CEO
TransEnterix (NYSE:TRXC) last week said it promoted Anthony Fernando to president and CEO, effective Nov. 8. Fernando previously served as the company’s chief operating officer and chief technology officer. He succeeds Todd Pope who is stepping down from his role as president and CEO and will serve as a senior advisor to the company. “We would […]
These 10 medtech companies care a lot about research
These 10 medical device companies spent the largest portion of their budgets on research and development. Here’s a look at what they produced. Each year, Medical Design & Outsourcing compiles a list of the top 100 medical device companies across the globe and ranks the companies based on annual revenue for the most recent fiscal year. We […]
TransEnterix pursues reverse split, share prices plunge
TransEnterix (NYSE:TRXC) said today that it plans to pursue a reverse stock split that could see it exchange a single share for as many as 40 shares. Companies often use reverse splits to buoy their share prices. Research Triangle Park, N.C.-based TransEnterix, which makes the Senhance robot-assisted surgery device, set the range on the proposed split […]
TransEnterix modifies AutoLap sale
TransEnterix (NYSE:TRXC) said yesterday that it agreed to amend a previously announced sale agreement with Great Belief International for the AutoLap system. On July 10, Research Triangle Park, N.C.-based TransEnterix announced that it dealt the AutoLap assets it had acquired in October 2018 along with Medical Surgery Technologies to Great Belief International for $47 million. This week, […]
TransEnterix seeks to raise $20.3m
TransEnterix (NYSE:TRXC) said that it has priced a public offering of 28 million shares of its common stock for gross proceeds of approximately $20.3 million. The Research Triangle Park, N.C.-based company also granted the underwriter a 30-day option to purchase approximately $3 million in additional shares of common stock. TransEnterix intends to use the net […]
TransEnterix shares dive on disappointing Q2 sales
Shares of TransEnterix (NYSE:TRXC) started inching back up this morning following a nearly 33% plunge yesterday fueled by disappointing second-quarter results. The Research Triangle Park, N.C.-based company posted losses of $20.1 million, or -10¢ per share, on sales of $3.64 million for the three months ended June 30, 2019. Adjusted to exclude one-time items, losses […]
